References
- Arimura, T., Helbling-Leclerc, A., Massart, C., Varnous, S., Niel, F., Lacene, E., Fromes, Y., Toussaint, M., Mura, A.M., Keller, D.I., et al. (2005). Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies. Hum. Mol. Genet. 14, 155-169. https://doi.org/10.1093/hmg/ddi017
- Badorff, C., Lee, G.H., Lamphear, B.J., Martone, M.E., Campbell, K.P., Rhoads, R.E., and Knowlton, K.U. (1999). Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat. Med. 5, 320-326. https://doi.org/10.1038/6543
- Bang, M.L., Centner, T., Fornoff, F., Geach, A.J., Gotthardt, M., McNabb, M., Witt, C.C., Labeit, D., Gregorio, C.C., Granzier, H., et al. (2001). The complete gene sequence of titin, expression of an unusual approximately 700-kDa titin isoform, and its interaction with obscurin identify a novel Z-disc to I-band linking system. Circ Res. 89, 1065-1072. https://doi.org/10.1161/hh2301.100981
- Berko, B.A., and Swift, M. (1987). X-linked dilated cardiomyopathy. N Engl. J. Med. 316, 1186-1191. https://doi.org/10.1056/NEJM198705073161904
- Bienengraeber, M., Olson, T.M., Selivanov, V.A., Kathmann, E.C., O'Cochlain, F., Gao, F., Karger, A.B., Ballew, J.D., Hodgson, D.M., Zingman, L.V., et al. (2004). ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating. Nat. Genet. 36, 382-387. https://doi.org/10.1038/ng1329
- Bonne, G., Di Barletta, M.R., Varnous, S., Becane, H.M., Hammouda, E.H., Merlini, L., Muntoni, F., Greenberg, C.R., Gary, F., Urtizberea, J.A., et al. (1999). Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat. Genet. 21, 285-288. https://doi.org/10.1038/6799
- Bonne, G., Mercuri, E., Muchir, A., Urtizberea, A., Becane, H.M., Recan, D., Merlini, L., Wehnert, M., Boor, R., Reuner, U., et al. (2000). Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene. Ann. Neurol. 48, 170-180. https://doi.org/10.1002/1531-8249(200008)48:2<170::AID-ANA6>3.0.CO;2-J
- Burke, B., and Gerace, L. (1986). A cell free system to study reassembly of the nuclear envelope at the end of mitosis. Cell 44, 639-652. https://doi.org/10.1016/0092-8674(86)90273-4
- Butin-Israeli, V., Adam, S.A., Goldman, A.E., and Goldman, R.D. (2012). Nuclear lamin functions and disease. Trends Genet. 28, 464-471. https://doi.org/10.1016/j.tig.2012.06.001
- Cao, H., and Hegele, R.A. (2000). Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum. Mol. Genet. 9, 109-112. https://doi.org/10.1093/hmg/9.1.109
- Choi, J.C., Muchir, A., Wu, W., Iwata, S., Homma, S., Morrow, J.P., and Worman, H.J. (2012). Temsirolimus activates autophagy and ameliorates cardiomyopathy caused by lamin A/C gene mutation. Sci. Transl. Med. 4, 144ra102. https://doi.org/10.1126/scitranslmed.3003875
- Codd, M.B., Sugrue, D.D., Gersh, B.J., and Melton, L.J., 3rd (1989). Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation 80, 564-572. https://doi.org/10.1161/01.CIR.80.3.564
- Debold, E.P., Schmitt, J.P., Patlak, J.B., Beck, S.E., Moore, J.R., Seidman, J.G., Seidman, C., and Warshaw, D.M. (2007). Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay. Am. J. Physiol. Heart Circ. Physiol. 293, H284-291. https://doi.org/10.1152/ajpheart.00128.2007
- Dellefave, L., and McNally, E.M. (2010). The genetics of dilated cardiomyopathy. Curr. Opin. Cardiol. 25, 198-204. https://doi.org/10.1097/HCO.0b013e328337ba52
- Emery, A.E. (2000). Emery-Dreifuss muscular dystrophy - a 40 year retrospective. Neuromuscul. Disord.10, 228-232. https://doi.org/10.1016/S0960-8966(00)00105-X
- Fatkin, D., MacRae, C., Sasaki, T., Wolff, M.R., Porcu, M., Frenneaux, M., Atherton, J., Vidaillet, H.J., Jr., Spudich, S., De Girolami, U., et al. (1999). Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl. J. Med. 341, 1715-1724. https://doi.org/10.1056/NEJM199912023412302
- Fatkin, D., Seidman, C.E., and Seidman, J.G. (2014). Genetics and disease of ventricular muscle. Cold Spring Harb. Perspect. Med. 4, a021063. https://doi.org/10.1101/cshperspect.a021063
- Gerace, L., and Blobel, G. (1980). The nuclear envelope lamina is reversibly depolymerized during mitosis. Cell 19, 277-287. https://doi.org/10.1016/0092-8674(80)90409-2
- Herman, D.S., Lam, L., Taylor, M.R., Wang, L., Teekakirikul, P., Christodoulou, D., Conner, L., DePalma, S.R., McDonough, B., Sparks, E., et al. (2012). Truncations of titin causing dilated cardiomyopathy. N Engl. J. Med. 366, 619-628. https://doi.org/10.1056/NEJMoa1110186
- Itoh-Satoh, M., Hayashi, T., Nishi, H., Koga, Y., Arimura, T., Koyanagi, T., Takahashi, M., Hohda, S., Ueda, K., Nouchi, T., et al. (2002). Titin mutations as the molecular basis for dilated cardiomyopathy. Biochem. Biophys. Res. Commun. 291, 385-393. https://doi.org/10.1006/bbrc.2002.6448
- Kamdar, F., and Garry, D.J. (2016). Dystrophin-deficient cardiomyopathy. J. Am. Coll. Cardiol. 67, 2533-2546. https://doi.org/10.1016/j.jacc.2016.02.081
- Kamisago, M., Sharma, S.D., DePalma, S.R., Solomon, S., Sharma, P., McDonough, B., Smoot, L., Mullen, M.P., Woolf, P.K., Wigle, E.D., et al. (2000). Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl. J. Med. 343, 1688-1696. https://doi.org/10.1056/NEJM200012073432304
- Kubben, N., Voncken, J.W., Konings, G., van Weeghel, M., van den Hoogenhof, M.M., Gijbels, M., van Erk, A., Schoonderwoerd, K., van den Bosch, B., Dahlmans, V., et al. (2011). Post-natal myogenic and adipogenic developmental: defects and metabolic impairment upon loss of A-type lamins. Nucleus 2, 195-207. https://doi.org/10.4161/nucl.2.3.15731
- Li, D., Tapscoft, T., Gonzalez, O., Burch, P.E., Quinones, M.A., Zoghbi, W.A., Hill, R., Bachinski, L.L., Mann, D.L., and Roberts, R. (1999). Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation 100, 461-464. https://doi.org/10.1161/01.CIR.100.5.461
- Maron, B.J., Towbin, J.A., Thiene, G., Antzelevitch, C., Corrado, D., Arnett, D., Moss, A.J., Seidman, C.E., Young, J.B., American Heart, A., et al. (2006). Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113, 1807-1816. https://doi.org/10.1161/CIRCULATIONAHA.106.174287
- Milner, D.J., Weitzer, G., Tran, D., Bradley, A., and Capetanaki, Y. (1996). Disruption of muscle architecture and myocardial degeneration in mice lacking desmin. J. Cell Biol. 134, 1255-1270. https://doi.org/10.1083/jcb.134.5.1255
- Miura, K., Nakagawa, H., Morikawa, Y., Sasayama, S., Matsumori, A., Hasegawa, K., Ohno, Y., Tamakoshi, A., Kawamura, T., and Inaba, Y. (2002). Epidemiology of idiopathic cardiomyopathy in Japan: results from a nationwide survey. Heart 87, 126-130. https://doi.org/10.1136/heart.87.2.126
- Morita, H., Seidman, J., and Seidman, C.E. (2005). Genetic causes of human heart failure. J. Clin. Invest. 115, 518-526. https://doi.org/10.1172/JCI24351
- Mortality, G.B.D., and Causes of Death, C. (2015). Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385, 117-171. https://doi.org/10.1016/S0140-6736(14)61682-2
- Muchir, A., Pavlidis, P., Decostre, V., Herron, A.J., Arimura, T., Bonne, G., and Worman, H.J. (2007). Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy. The Journal of clinical investigation 117, 1282-1293. https://doi.org/10.1172/JCI29042
- Muchir, A., Shan, J., Bonne, G., Lehnart, S.E., and Worman, H.J. (2009). Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins. Hum. Mol. Genet. 18, 241-247.
- Muntoni, F., Cau, M., Ganau, A., Congiu, R., Arvedi, G., Mateddu, A., Marrosu, M.G., Cianchetti, C., Realdi, G., Cao, A., et al. (1993). Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl. J. Med. 329, 921-925. https://doi.org/10.1056/NEJM199309233291304
- Nikolova, V., Leimena, C., McMahon, A.C., Tan, J.C., Chandar, S., Jogia, D., Kesteven, S.H., Michalicek, J., Otway, R., Verheyen, F., et al. (2004). Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice. J. Clin. Invest. 113, 357-369. https://doi.org/10.1172/JCI200419448
- Olson, T.M., Michels, V.V., Ballew, J.D., Reyna, S.P., Karst, M.L., Herron, K.J., Horton, S.C., Rodeheffer, R.J., and Anderson, J.L. (2005). Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. Jama 293, 447-454. https://doi.org/10.1001/jama.293.4.447
- Parks, S.B., Kushner, J.D., Nauman, D., Burgess, D., Ludwigsen, S., Peterson, A., Li, D., Jakobs, P., Litt, M., Porter, C.B., et al. (2008). Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy. Am. Heart J. 156, 161-169. https://doi.org/10.1016/j.ahj.2008.01.026
- Perrot, A., Hussein, S., Ruppert, V., Schmidt, H.H., Wehnert, M.S., Duong, N.T., Posch, M.G., Panek, A., Dietz, R., Kindermann, I., et al. (2009). Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy. Basic Res. Cardiol. 104, 90-99. https://doi.org/10.1007/s00395-008-0748-6
- Raffaele Di Barletta, M., Ricci, E., Galluzzi, G., Tonali, P., Mora, M., Morandi, L., Romorini, A., Voit, T., Orstavik, K.H., Merlini, L., et al. (2000). Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. Am. J. Hum. Genet. 66, 1407-1412. https://doi.org/10.1086/302869
- Ramos, F.J., Chen, S.C., Garelick, M.G., Dai, D.F., Liao, C.Y., Schreiber, K.H., MacKay, V.L., An, E.H., Strong, R., Ladiges, W.C., et al. (2012). Rapamycin reverses elevated mTORC1 signaling in lamin A/C-deficient mice, rescues cardiac and skeletal muscle function, and extends survival. Sci. Transl. Med. 4, 144ra103. https://doi.org/10.1126/scitranslmed.3003802
- Sanbe, A. (2013). Dilated cardiomyopathy: a disease of the myocardium. Biol. Pharm. Bull. 36, 18-22.
- Schmitt, J.P., Kamisago, M., Asahi, M., Li, G.H., Ahmad, F., Mende, U., Kranias, E.G., MacLennan, D.H., Seidman, J.G., and Seidman, C.E. (2003). Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 299, 1410-1413. https://doi.org/10.1126/science.1081578
- Schmitt, J.P., Debold, E.P., Ahmad, F., Armstrong, A., Frederico, A., Conner, D.A., Mende, U., Lohse, M.J., Warshaw, D., Seidman, C.E., et al. (2006). Cardiac myosin missense mutations cause dilated cardiomyopathy in mouse models and depress molecular motor function. Proc. Natl. Acad. Sci. USA 103, 14525-14530. https://doi.org/10.1073/pnas.0606383103
- Stewart, C.L., Roux, K.J., and Burke, B. (2007). Blurring the boundary: the nuclear envelope extends its reach. Science 318, 1408-1412. https://doi.org/10.1126/science.1142034
- Sullivan, T., Escalante-Alcalde, D., Bhatt, H., Anver, M., Bhat, N., Nagashima, K., Stewart, C.L., and Burke, B. (1999). Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J. Cell Biol. 147, 913-920. https://doi.org/10.1083/jcb.147.5.913
- Tsubata, S., Bowles, K.R., Vatta, M., Zintz, C., Titus, J., Muhonen, L., Bowles, N.E., and Towbin, J.A. (2000). Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J. Clin. Invest. 106, 655-662. https://doi.org/10.1172/JCI9224
- van Tintelen, J.P., Hofstra, R.M., Katerberg, H., Rossenbacker, T., Wiesfeld, A.C., du Marchie Sarvaas, G.J., Wilde, A.A., van Langen, I.M., Nannenberg, E.A., van der Kooi, A.J., et al. (2007). High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics. Am. Heart J. 154, 1130-1139. https://doi.org/10.1016/j.ahj.2007.07.038
- Villard, E., Duboscq-Bidot, L., Charron, P., Benaiche, A., Conraads, V., Sylvius, N., and Komajda, M. (2005). Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene. Eur. Heart J. 26, 794-803. https://doi.org/10.1093/eurheartj/ehi193
- Wolf, C.M., Wang, L., Alcalai, R., Pizard, A., Burgon, P.G., Ahmad, F., Sherwood, M., Branco, D.M., Wakimoto, H., Fishman, G.I., et al. (2008). Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease. J. Mol. Cell. Cardiol. 44, 293-303. https://doi.org/10.1016/j.yjmcc.2007.11.008
- Wu, W., Muchir, A., Shan, J., Bonne, G., and Worman, H.J. (2011). Mitogen-activated protein kinase inhibitors improve heart function and prevent fibrosis in cardiomyopathy caused by mutation in lamin A/C gene. Circulation 123, 53-61. https://doi.org/10.1161/CIRCULATIONAHA.110.970673
Cited by
- Data on whole length myosin binding protein C stabilizes myosin S2 as measured by gravitational force spectroscopy vol.18, pp.None, 2016, https://doi.org/10.1016/j.dib.2018.04.002
- Personalized medicine in inflammatory cardiomyopathy vol.15, pp.2, 2018, https://doi.org/10.2217/pme-2017-0074
- Identification of a LMNA (c.646C>T) variant by whole-exome sequencing in combination with a dilated cardiomyopathy (DCM) related gene filter in a family with familiar DCM vol.32, pp.4, 2016, https://doi.org/10.7555/jbr.32.20180003
- Filamin C Cardiomyopathy Variants Cause Protein and Lysosome Accumulation vol.129, pp.7, 2016, https://doi.org/10.1161/circresaha.120.317076
- MicroRNAs: From Junk RNA to Life Regulators and Their Role in Cardiovascular Disease vol.11, pp.4, 2016, https://doi.org/10.3390/cardiogenetics11040023